
Sign up to save your podcasts
Or


Dr. Zeidan shares his thoughts on the recent news that the VERONA trial in high-risk MDS was negative.
By Chadi NabhanDr. Zeidan shares his thoughts on the recent news that the VERONA trial in high-risk MDS was negative.